You can buy or sell Orgenesis and other stocks, options, ETFs, and crypto commission-free!
Orgenesis Inc. Common Stock, also called Orgenesis, is a biotechnology company, which engages in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry. Read More It operates through the Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CT) segments. The CDMO segment through MaSTherCell, comprises of comprehensive services from cell therapy development through cell therapy manufacturing for and companies that provide end-to-end solution. The CT segment includes a technology that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and trans-differentiating them into pancreatic beta cell-like insulin-producing cells. The company was founded on June 5, 2008 by Sarah Ferber and is headquartered in Germantown, MD.
52 Week High
52 Week Low
Expected Feb 8, Pre-Market